BN Business News
Add your company to Business Communicator →

Business · 09/03/2012

FDA Classifies Norovirus Serological Reagents as Class II Devices with Special Controls

The FDA has classified norovirus serological reagents into Class II devices, which will be subject to special controls outlined in the 'Class II Special Controls Guidance Document: Norovirus Serological Reagents' to ensure safety and effectiveness.

Original source language: Federal Register — Food and Drug AdministrationOpen original release →

Explore insights